Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News

World Cancer Day: Commercial interests drive millions of avoidable cancer deaths
World Cancer Day: Commercial interests drive millions of avoidable cancer deaths
FDA grants accelerated approval to pirtobrutinib for relapsed or refractory mantle cell lymphoma
FDA grants accelerated approval to pirtobrutinib for relapsed or refractory mantle cell lymphoma
FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation